first-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma
Published 5 years ago • 2K plays • Length 6:46Download video MP4
Download video MP3
Similar videos
-
1:13
keynote-b84: pepinemab pembrolizumab for metastatic/recurrent head & neck squamous cell carcinoma
-
5:24
keynote048: first line pembrolizumab for r/m hnscc
-
2:37
pembrolizumab is effective in recurrent, metastatic squamous cell carcinomas of the head and neck
-
1:58
dr. rischin on keynote-048 results in head and neck squamous cell carcinoma
-
4:42
pembrolizumab for recurrent head and neck squamous cell carcinomas (hnscc)
-
5:05
pembrolizumab vs. standard treatment in patients with recurrent or metastatic head and neck cancer
-
7:03
lba8_pr - keynote-048: phase 3 study of first-line pembrolizumab in r/m hnscc
-
6:35
pembrolizumab as first-line therapy for recurrent/metastatic head and neck cancer
-
6:17
pembrolizumab for head and neck cancer
-
7:13
first-line pembrolizumab plus chemotherapy for patients with advanced squamous nsclc: 3-year fol...
-
7:38
pembrolizumab shows promising activity against head and neck cancer
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
2:35
pembrolizumab/carboplatin/paclitaxel combo shows antitumour activity in first-line recurrent/met...
-
28:48
the changing treatment landscape in recurrent/metastatic squamous cell carcinoma of head & neck
-
1:48
post hoc keynote-040 analysis: pembrolizumab for hnscc produces lasting immune effect
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
5:34
pembrolizumab for recurrent hnscc
-
2:45
final keynote-048 results with frontline pembrolizumab in recurrent/metastatic hnscc
-
0:58
development of a vaccine for pre-treated head & neck squamous cell carcinoma